微创二尖瓣手术的发展前景与展望

发布时间：2018-04-17 11:37

本文选题：微创 + 二尖瓣　；参考：《南昌大学》2017年硕士论文

【摘要】：风湿性心脏瓣膜病是目前发展中国家最常见的导致年轻人死亡的心血管疾病之一,风湿热引起的瓣膜病变中以二尖瓣最常受累。手术治疗是目前临床上最有效的治疗方法。与传统正中开胸手术相比,微创心脏手术拥有明显较小的术中创伤,术后低并发症的发生,患者更少住院天数,在外观上更能被患者所接受等优点,越来越流行,并有可能替代传统正中开胸方式。本综述通过阐述微创二尖瓣手术的发展历程,并分别阐述胸骨部分切开手术入路、右侧胸壁小切口入路、胸腔镜辅助微创心脏手术及机器人辅助微创心脏手术这4种不同入路方式微创二尖瓣手术的安全性、可行性、疗效及预后等,探讨未来微创二尖瓣手术的发展趋势及前景。
[Abstract]:Rheumatic valvular disease is one of the most common cardiovascular diseases leading to death in young people in developing countries, and mitral valve is the most frequently involved in valvular disease caused by rheumatic fever.Surgical treatment is the most effective method in clinic.Compared with the traditional median thoracotomy, minimally invasive cardiac surgery has the advantages of less trauma, lower postoperative complications, fewer hospital days, more acceptable to patients in appearance, and more and more popular.And it is possible to replace the traditional central thoracotomy.This article reviews the development of minimally invasive mitral valve surgery, and describes the approach of partial sternotomy and small incision of right chest wall, respectively.The safety, feasibility, curative effect and prognosis of minimally invasive mitral valve surgery by thoracoscopic assisted minimally invasive cardiac surgery and robot-assisted minimally invasive cardiac surgery were studied. The development trend and prospect of minimally invasive mitral valve surgery in the future were discussed.
【学位授予单位】：南昌大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：R654.2

【参考文献】